Concentrix (NASDAQ:CNXC) Given Buy Rating at Canaccord Genuity Group

Canaccord Genuity Group reissued their buy rating on shares of Concentrix (NASDAQ:CNXCFree Report) in a research note published on Thursday morning, Benzinga reports. Canaccord Genuity Group currently has a $125.00 price objective on the stock.

Other equities research analysts have also recently issued research reports about the company. Barrington Research restated an outperform rating and set a $84.00 target price on shares of Concentrix in a research note on Friday, June 21st. Scotiabank decreased their target price on Concentrix from $120.00 to $85.00 and set a sector outperform rating for the company in a research note on Monday, April 29th. Finally, Bank of America restated an underperform rating and set a $60.00 target price (down previously from $85.00) on shares of Concentrix in a research note on Wednesday, March 27th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Concentrix has an average rating of Hold and a consensus target price of $84.80.

Get Our Latest Stock Report on Concentrix

Concentrix Stock Performance

Shares of CNXC opened at $63.28 on Thursday. The stock has a 50-day simple moving average of $60.39 and a 200-day simple moving average of $73.04. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.56 and a current ratio of 1.54. The stock has a market capitalization of $4.18 billion, a PE ratio of 14.65, a PEG ratio of 0.74 and a beta of 0.60. Concentrix has a 1 year low of $53.89 and a 1 year high of $106.10.

Concentrix (NASDAQ:CNXCGet Free Report) last posted its earnings results on Wednesday, June 26th. The company reported $2.69 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.06. The firm had revenue of $2.38 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Concentrix had a return on equity of 17.00% and a net margin of 3.08%. The firm’s revenue was up 47.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.50 earnings per share. On average, analysts predict that Concentrix will post 10.62 earnings per share for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 6th. Stockholders of record on Friday, July 26th will be paid a dividend of $0.303 per share. The ex-dividend date of this dividend is Friday, July 26th. This represents a $1.21 annualized dividend and a dividend yield of 1.92%. Concentrix’s dividend payout ratio (DPR) is 28.01%.

Insider Buying and Selling

In related news, CEO Christopher A. Caldwell acquired 900 shares of the firm’s stock in a transaction on Friday, April 19th. The stock was bought at an average cost of $54.59 per share, with a total value of $49,131.00. Following the transaction, the chief executive officer now owns 239,128 shares of the company’s stock, valued at $13,053,997.52. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 3.00% of the company’s stock.

Institutional Trading of Concentrix

A number of hedge funds have recently added to or reduced their stakes in CNXC. First Horizon Advisors Inc. lifted its position in Concentrix by 381.7% during the 4th quarter. First Horizon Advisors Inc. now owns 342 shares of the company’s stock worth $34,000 after acquiring an additional 271 shares during the period. Pineridge Advisors LLC acquired a new stake in shares of Concentrix in the 4th quarter valued at approximately $35,000. Parkside Financial Bank & Trust lifted its holdings in shares of Concentrix by 146.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 630 shares of the company’s stock valued at $62,000 after buying an additional 374 shares during the period. Blue Trust Inc. lifted its holdings in shares of Concentrix by 29.8% in the 4th quarter. Blue Trust Inc. now owns 1,151 shares of the company’s stock valued at $113,000 after buying an additional 264 shares during the period. Finally, Covestor Ltd lifted its holdings in shares of Concentrix by 49.8% in the 1st quarter. Covestor Ltd now owns 1,918 shares of the company’s stock valued at $127,000 after buying an additional 638 shares during the period. 90.34% of the stock is owned by institutional investors and hedge funds.

About Concentrix

(Get Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

See Also

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.